Tayar, E. and Kodali, D. 2025. Delayed-onset vitiligo in metastatic HR+/HER2– breast cancer during long-term ribociclib therapy. European Journal of Case Reports in Internal Medicine. 13, 1 (Dec. 2025). DOI:https://doi.org/10.12890/2025_006043.